Antiangiogenic Targets for Glioblastoma Therapy from a Pre-Clinical Approach, Using Nanoformulations

Antiangiogenic Targets for Glioblastoma Therapy from a Pre-Clinical Approach, Using Nanoformulations

Glioblastoma (GBM) is the most aggressive tumor type whose resistance to conventional treatment is mediated, in part, by the angiogenic process. New treatments involving the application of nanoformulations composed of encapsulated drugs coupled to peptide motifs that direct drugs to specific targets...

Full description

Bibliographic Details
Main Authors: Gabriel Nery de Albuquerque Rego, Arielly da Hora Alves, Mariana Penteado Nucci, Javier Bustamante Mamani, Fernando Anselmo de Oliveira, Lionel Fernel Gamarra
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:International Journal of Molecular Sciences
Subjects:
glioblastoma
GBM
nanoparticle
nanomedicine
nanotherapy
angiogenesis
Online Access:https://www.mdpi.com/1422-0067/21/12/4490

Internet

https://www.mdpi.com/1422-0067/21/12/4490

Similar Items